Skip to main content
Top
Published in: Respiratory Research 1/2021

Open Access 01-12-2021 | Chronic Obstructive Lung Disease | Research

The “can do, do do” concept in individuals with chronic obstructive pulmonary disease: an exploration of psychological mechanisms

Authors: J. Carl, K. Schultz, T. Janssens, A. von Leupoldt, K. Pfeifer, W. Geidl

Published in: Respiratory Research | Issue 1/2021

Login to get access

Abstract

Background

The “can do, do do” concept aims at identifying subgroups among persons with chronic obstructive pulmonary disease (COPD). Following a two-dimensional categorization, individuals are binarily classified with respect to their levels of physical capacity (“can’t do” or “can do”) and physical activity (“don’t do” or “do do”), resulting in four disjunct quadrants. The approach has been debated recently and the latest articles have concluded that the quadrants should be specifically examined in terms of psychological aspects of physical activity. Therefore, the goal of the present study was to explore the role of psychological variables in physical activity in the context of the “can do, do do” quadrant concept.

Methods

Within the scope of secondary data analyses of the “Stay Active After Rehabilitation” (STAR) randomized controlled trial, a total of 298 COPD rehabilitants of an inpatient pulmonary rehabilitation program were grouped into the suggested quadrants. We set fixed cut-offs at 70% of relative 6-min walking test performances for healthy individuals (physical capacity dimension) and 5.000 steps per day (physical activity dimension). Univariate and multivariate logistic regression analyses served to analyze whether depression scores, fear avoidance behaviors, disease-specific anxiety, self-concordance for physical activity, and five indicators of physical activity-related health competence (PAHCO) effectively discriminated between the “don’t do” and “do do” groups.

Results

Among persons with lower relative physical capacity, depression scores, fear avoidance behaviors, and disease-specific anxiety (univariate case) significantly differentiated between the more and the less active. Among persons with higher relative physical capacity, fear avoidance behaviors, disease-specific anxiety, as well as three PAHCO indicators (physical activity-specific self-efficacy, self-control, and affect regulation) significantly separated the more and the less active. In multivariate analyses, only fear avoidance behaviors and affect regulation discriminated among individuals with better relative physical capacity.

Conclusion

The findings identified important psychological and competence-oriented variables that explain discrepancies in the quadrant concept. Based on this, we discuss implications for physical activity promotion in individuals with COPD. Respiratory research can benefit from future studies complementing the quadrant concept through further behavioral analyses.
Trial registration Clinicaltrials.gov, ID: NCT02966561. Registered 17 November, 2016, https://​clinicaltrials.​gov/​ct2/​show/​NCT02966561.
Literature
1.
go back to reference James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858. https://doi.org/10.1016/S0140-6736(18)32279-7.CrossRef James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858. https://​doi.​org/​10.​1016/​S0140-6736(18)32279-7.CrossRef
2.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.CrossRef Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.CrossRef
5.
go back to reference Geidl W, Deprins J, Cassar S, Streber R, Portenlänger F, Sudeck G, Pfeifer K. Exercise therapy and physical activity promotion: do exercise therapists assess or receive information on clients’ relevant personal factors? A national survey from Germany. Eur J Physiother. 2020;22:290–8.CrossRef Geidl W, Deprins J, Cassar S, Streber R, Portenlänger F, Sudeck G, Pfeifer K. Exercise therapy and physical activity promotion: do exercise therapists assess or receive information on clients’ relevant personal factors? A national survey from Germany. Eur J Physiother. 2020;22:290–8.CrossRef
8.
go back to reference Geidl W, Carl J, Cassar S, Lehbert N, Mino E, Wittmann M, et al. Physical activity and sedentary behaviour patterns in 326 persons with COPD before starting a pulmonary rehabilitation: a cluster analysis. J Clin Med. 2019;8:1346.CrossRef Geidl W, Carl J, Cassar S, Lehbert N, Mino E, Wittmann M, et al. Physical activity and sedentary behaviour patterns in 326 persons with COPD before starting a pulmonary rehabilitation: a cluster analysis. J Clin Med. 2019;8:1346.CrossRef
9.
go back to reference World Health Organization. International Classification of Functioning, Disability and Health: ICF. Geneva, Switzerland: ICF; 2001. World Health Organization. International Classification of Functioning, Disability and Health: ICF. Geneva, Switzerland: ICF; 2001.
10.
go back to reference Üstün TB, Chatterji S, Bickenbach J, Kostanjsek N, Schneider M. The international classification of functioning, disability and health: a new tool for understanding disability and health. Disabil Rehabil. 2003;25:565–71.CrossRef Üstün TB, Chatterji S, Bickenbach J, Kostanjsek N, Schneider M. The international classification of functioning, disability and health: a new tool for understanding disability and health. Disabil Rehabil. 2003;25:565–71.CrossRef
14.
go back to reference Sievi NA, Kohler M, Clarenbach CF. Respond to the letter to the editor by Van Hul et al. regarding the published manuscript "can do, don't do" are not the lazy ones: a longitudinal study on physical functioning in patients with COPD" by Sievi et al. (1). Respir Res. 2020;21:114. https://doi.org/10.1186/s12931-020-01376-2. Sievi NA, Kohler M, Clarenbach CF. Respond to the letter to the editor by Van Hul et al. regarding the published manuscript "can do, don't do" are not the lazy ones: a longitudinal study on physical functioning in patients with COPD" by Sievi et al. (1). Respir Res. 2020;21:114. https://​doi.​org/​10.​1186/​s12931-020-01376-2.
15.
go back to reference Reijnders T, Schuler M, Wittmann M, Jelusic D, Troosters T, Janssens W, et al. The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD. Respir Med. 2019;146:87–95.CrossRef Reijnders T, Schuler M, Wittmann M, Jelusic D, Troosters T, Janssens W, et al. The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD. Respir Med. 2019;146:87–95.CrossRef
16.
go back to reference Janssens T, van de Moortel Z, Geidl W, Carl J, Pfeifer K, Lehbert N, et al. Impact of disease-specific fears on pulmonary rehabilitation trajectories in patients with COPD. J Clin Med. 2019;8:1460.CrossRef Janssens T, van de Moortel Z, Geidl W, Carl J, Pfeifer K, Lehbert N, et al. Impact of disease-specific fears on pulmonary rehabilitation trajectories in patients with COPD. J Clin Med. 2019;8:1460.CrossRef
17.
go back to reference Dueñas-Espín I, Demeyer H, Gimeno-Santos E, Polkey MI, Hopkinson NS, Rabinovich RA, et al. Depression symptoms reduce physical activity in COPD patients: a prospective multicenter study. Int J Chron Obstruct Pulmon Dis. 2016;11:1287.CrossRef Dueñas-Espín I, Demeyer H, Gimeno-Santos E, Polkey MI, Hopkinson NS, Rabinovich RA, et al. Depression symptoms reduce physical activity in COPD patients: a prospective multicenter study. Int J Chron Obstruct Pulmon Dis. 2016;11:1287.CrossRef
18.
go back to reference Thorpe O, Johnston K, Kumar S. Barriers and enablers to physical activity participation in patients with COPD: a systematic review. J Cardiopulm Rehabil Prev. 2012;32:359–69.CrossRef Thorpe O, Johnston K, Kumar S. Barriers and enablers to physical activity participation in patients with COPD: a systematic review. J Cardiopulm Rehabil Prev. 2012;32:359–69.CrossRef
19.
go back to reference Larsson C, Hansson EE, Sundquist K, Jakobsson U. Impact of pain characteristics and fear-avoidance beliefs on physical activity levels among older adults with chronic pain: a population-based, longitudinal study. BMC Geriatr. 2016;16:1–8.CrossRef Larsson C, Hansson EE, Sundquist K, Jakobsson U. Impact of pain characteristics and fear-avoidance beliefs on physical activity levels among older adults with chronic pain: a population-based, longitudinal study. BMC Geriatr. 2016;16:1–8.CrossRef
20.
go back to reference Kosteli M-C, Heneghan NR, Roskell C, Williams SE, Adab P, Dickens AP, et al. Barriers and enablers of physical activity engagement for patients with COPD in primary care. Int J Chron Obstruct Pulmon Dis. 2017;12:1019.CrossRef Kosteli M-C, Heneghan NR, Roskell C, Williams SE, Adab P, Dickens AP, et al. Barriers and enablers of physical activity engagement for patients with COPD in primary care. Int J Chron Obstruct Pulmon Dis. 2017;12:1019.CrossRef
27.
go back to reference Geidl W, Semrau J, Streber R, Lehbert N, Wingart S, Tallner A, et al. Effects of a brief, pedometer-based behavioral intervention for individuals with COPD during inpatient pulmonary rehabilitation on 6-week and 6-month objectively measured physical activity: study protocol for a randomized controlled trial. Trials. 2017;18: e13. https://doi.org/10.1186/s13063-017-2124-z.CrossRef Geidl W, Semrau J, Streber R, Lehbert N, Wingart S, Tallner A, et al. Effects of a brief, pedometer-based behavioral intervention for individuals with COPD during inpatient pulmonary rehabilitation on 6-week and 6-month objectively measured physical activity: study protocol for a randomized controlled trial. Trials. 2017;18: e13. https://​doi.​org/​10.​1186/​s13063-017-2124-z.CrossRef
28.
29.
go back to reference Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999;14:270–4.CrossRef Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999;14:270–4.CrossRef
30.
go back to reference Rabinovich RA, Louvaris Z, Raste Y, Langer D, van Remoortel H, Giavedoni S, et al. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J. 2013;42:1205–15.CrossRef Rabinovich RA, Louvaris Z, Raste Y, Langer D, van Remoortel H, Giavedoni S, et al. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J. 2013;42:1205–15.CrossRef
31.
go back to reference Byrom B, Rowe DA. Measuring free-living physical activity in COPD patients: deriving methodology standards for clinical trials through a review of research studies. Contemp Clin Trials. 2016;47:172–84.CrossRef Byrom B, Rowe DA. Measuring free-living physical activity in COPD patients: deriving methodology standards for clinical trials through a review of research studies. Contemp Clin Trials. 2016;47:172–84.CrossRef
33.
go back to reference Löwe B, Spitzer R, Zipfel S, Herzog W. Gesundheitsfragebogen für Patienten (PHQ-D). Komplettversion und Kurzform. Testmappe mit Manual, Fragebögen, Schablonen. Karlsruhe: Pfizer; 2002. Löwe B, Spitzer R, Zipfel S, Herzog W. Gesundheitsfragebogen für Patienten (PHQ-D). Komplettversion und Kurzform. Testmappe mit Manual, Fragebögen, Schablonen. Karlsruhe: Pfizer; 2002.
34.
go back to reference Kühl K, Kuhn C, Kenn K, Rief W. Der COPD-Angst-Fragebogen (CAF): Ein neues Instrument zur Erfassung krankheitsspezifischer Ängste bei COPD-Patienten [The COPD-Anxiety-Questionnaire (CAF): a new instrument to assess illness specific anxiety in COPD patients]. Psychother Psychosom Med Psychol. 2011;61:e1–9.CrossRef Kühl K, Kuhn C, Kenn K, Rief W. Der COPD-Angst-Fragebogen (CAF): Ein neues Instrument zur Erfassung krankheitsspezifischer Ängste bei COPD-Patienten [The COPD-Anxiety-Questionnaire (CAF): a new instrument to assess illness specific anxiety in COPD patients]. Psychother Psychosom Med Psychol. 2011;61:e1–9.CrossRef
35.
go back to reference Stenzel N, Rief W, Kenn K. The impact of illness perception and fear avoidance on disability in COPD. Eur Respir J. 2014;44:P3674. Stenzel N, Rief W, Kenn K. The impact of illness perception and fear avoidance on disability in COPD. Eur Respir J. 2014;44:P3674.
36.
go back to reference Solomon BK, Wilson KG, Henderson PR, Poulin PA, Kowal J, McKim DA. A Breathlessness Catastrophizing Scale for chronic obstructive pulmonary disease. J Psychosom Res. 2015;79:62–8.CrossRef Solomon BK, Wilson KG, Henderson PR, Poulin PA, Kowal J, McKim DA. A Breathlessness Catastrophizing Scale for chronic obstructive pulmonary disease. J Psychosom Res. 2015;79:62–8.CrossRef
37.
go back to reference Seelig H, Fuchs R. Messung der sport-und bewegungsbezogenen Selbstkonkordanz [Measuring sport- and movement-related self concordance]. Z Sportpsychol. 2006;13:121–39.CrossRef Seelig H, Fuchs R. Messung der sport-und bewegungsbezogenen Selbstkonkordanz [Measuring sport- and movement-related self concordance]. Z Sportpsychol. 2006;13:121–39.CrossRef
38.
go back to reference Ardelean DL, Iulia L, Popescu R, Didilescu C, Dinescu S, Olteanu M, Niţu M. Evaluation of COPD patients using CAT-COPD assessment test. Pneumologia. 2012;61:221–9.PubMed Ardelean DL, Iulia L, Popescu R, Didilescu C, Dinescu S, Olteanu M, Niţu M. Evaluation of COPD patients using CAT-COPD assessment test. Pneumologia. 2012;61:221–9.PubMed
39.
go back to reference Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. Am Rev Respir Dis. 1992;145:1321–7.CrossRef Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. Am Rev Respir Dis. 1992;145:1321–7.CrossRef
40.
go back to reference von Leupoldt A, Janssens T. Could targeting disease specific fear and anxiety improve COPD outcomes? Expert Rev Respir Med. 2016;10:835–7.CrossRef von Leupoldt A, Janssens T. Could targeting disease specific fear and anxiety improve COPD outcomes? Expert Rev Respir Med. 2016;10:835–7.CrossRef
41.
go back to reference Coventry PA, Gellatly JL. Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: a systematic review of cognitive behavioural therapy. Br J Health Psychol. 2008;13:381–400.CrossRef Coventry PA, Gellatly JL. Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: a systematic review of cognitive behavioural therapy. Br J Health Psychol. 2008;13:381–400.CrossRef
43.
go back to reference Coventry PA, Bower P, Keyworth C, Kenning C, Knopp J, Garrett C, et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS ONE. 2013;8:e60532.CrossRef Coventry PA, Bower P, Keyworth C, Kenning C, Knopp J, Garrett C, et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS ONE. 2013;8:e60532.CrossRef
44.
go back to reference Gordon CS, Waller JW, Cook RM, Cavalera SL, Lim WT, Osadnik CR. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: a systematic review and meta-analysis. Chest. 2019;156:80–91.CrossRef Gordon CS, Waller JW, Cook RM, Cavalera SL, Lim WT, Osadnik CR. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: a systematic review and meta-analysis. Chest. 2019;156:80–91.CrossRef
47.
go back to reference Saunders T, Campbell N, Jason T, Dechman G, Hernandez P, Thompson K, Blanchard CM. Objectively measured steps/day in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Phys Act Health. 2016;13:1275–83.CrossRef Saunders T, Campbell N, Jason T, Dechman G, Hernandez P, Thompson K, Blanchard CM. Objectively measured steps/day in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Phys Act Health. 2016;13:1275–83.CrossRef
48.
go back to reference Opasich C, Pinna GD, Mazza A, Febo O, Riccardi PG, Capomolla S, et al. Reproducibility of the six-minute walking test in patients with chronic congestive heart failure: practical implications. Am J Cardiol. 1998;81:1497–500.CrossRef Opasich C, Pinna GD, Mazza A, Febo O, Riccardi PG, Capomolla S, et al. Reproducibility of the six-minute walking test in patients with chronic congestive heart failure: practical implications. Am J Cardiol. 1998;81:1497–500.CrossRef
51.
go back to reference Antonovsky A. The salutogenic model as a theory to guide health promotion. Health Promot Int. 1996;11:11–8.CrossRef Antonovsky A. The salutogenic model as a theory to guide health promotion. Health Promot Int. 1996;11:11–8.CrossRef
Metadata
Title
The “can do, do do” concept in individuals with chronic obstructive pulmonary disease: an exploration of psychological mechanisms
Authors
J. Carl
K. Schultz
T. Janssens
A. von Leupoldt
K. Pfeifer
W. Geidl
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2021
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-021-01854-1

Other articles of this Issue 1/2021

Respiratory Research 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.